The natural course of MRI white matter hyperintensities

被引:38
作者
Schmidt, R
Schmidt, H
Kapeller, P
Enzinger, C
Ropele, S
Saurugg, R
Fazekas, F
机构
[1] Karl Franzens Univ Graz, Dept Neurol, A-8036 Graz, Austria
[2] Karl Franzens Univ Graz, Inst Med Biochem & Med Mol Biol, Graz, Austria
[3] Karl Franzens Univ Graz, MRI Ctr, Graz, Austria
关键词
small vessel disease; white matter lesions; MRI; risk factors; cognition;
D O I
10.1016/S0022-510X(02)00300-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The rate and extent of progression of white matter hyperintensities (WMH) over time in elderly subjects is yet unclear. These abnormalities may represent an early form of subcortical vascular dementia. As to whether such changes could be used, as a surrogate marker for this subtype of vascular dementia remains to be determined. So far there exists only a very limited number of studies determining the rate, clinical predictors and cognitive consequences of WMH evolution. There is evidence that these changes do progress over time, however the results of the different studies cannot be compared due to methodological differences. The Austrian Stroke Prevention Study reported that 17.9% of normal individuals show progression over time. The only published quantitative data demonstrated an absolute increase of 1.1 cm(3) over an observational period of 4 years in healthy subjects. Diastolic blood pressure, early confluent or confluent WMH at baseline and genetic variants in the angiotensinogen gene are so far the only known predictors of WMH progression. The Austrian Stroke Prevention Study did not find an association between the evolution of WMH and cognitive functioning but the statistical power of this analysis was small and the relationship needs to be further explored. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:253 / 257
页数:5
相关论文
共 15 条
[1]   INCIDENTAL SUBCORTICAL LESIONS IDENTIFIED ON MAGNETIC-RESONANCE-IMAGING IN THE ELDERLY .2. POSTMORTEM PATHOLOGICAL CORRELATIONS [J].
AWAD, IA ;
JOHNSON, PC ;
SPETZLER, RF ;
HODAK, JA .
STROKE, 1986, 17 (06) :1090-1097
[2]  
BRUNNEMANN B, 1992, J CARDIOVASC PHAR S6, V19, pS51
[3]   Angiotensin II receptor antagonists [J].
Burnier, M ;
Brunner, HR .
LANCET, 2000, 355 (9204) :637-645
[4]   Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins [J].
Carmelli, D ;
DeCarli, C ;
Swan, GE ;
Jack, LM ;
Reed, T ;
Wolf, PA ;
Miller, BL .
STROKE, 1998, 29 (06) :1177-1181
[5]   WHITE MATTER SIGNAL ABNORMALITIES IN NORMAL INDIVIDUALS - CORRELATION WITH CAROTID ULTRASONOGRAPHY, CEREBRAL BLOOD-FLOW MEASUREMENTS, AND CEREBROVASCULAR RISK-FACTORS [J].
FAZEKAS, F ;
NIEDERKORN, K ;
SCHMIDT, R ;
OFFENBACHER, H ;
HORNER, S ;
BERTHA, G ;
LECHNER, H .
STROKE, 1988, 19 (10) :1285-1288
[6]   ANGIOTENSIN-CONVERTING ENZYME GENE DELETION POLYMORPHISM - A NEW RISK FACTOR FOR LACUNAR STROKE BUT NOT CAROTID ATHEROMA [J].
MARKUS, HS ;
BARLEY, J ;
LUNT, R ;
BLAND, JM ;
JEFFERY, S ;
CARTER, ND ;
BROWN, MM .
STROKE, 1995, 26 (08) :1329-1333
[7]  
MAYHEW TM, 1991, J ANAT, V178, P133
[8]   THE SIGNIFICANCE OF CEREBRAL WHITE-MATTER ABNORMALITIES 100 YEARS AFTER BINSWANGERS REPORT - A REVIEW [J].
PANTONI, L ;
GARCIA, JH .
STROKE, 1995, 26 (07) :1293-1301
[9]   A SEMIQUANTITATIVE RATING-SCALE FOR THE ASSESSMENT OF SIGNAL HYPERINTENSITIES ON MAGNETIC-RESONANCE-IMAGING [J].
SCHELTENS, P ;
BARKHOF, F ;
LEYS, D ;
PRUVO, JP ;
NAUTA, JJP ;
VERMERSCH, P ;
STEINLING, M ;
VALK, J .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1993, 114 (01) :7-12
[10]   Angiotensinogen gene promoter haplotype and microangiopathy-related cerebral damage - Results of the Austrian Stroke Prevention Study [J].
Schmidt, H ;
Fazekas, F ;
Kostner, GM ;
van Duijn, CM ;
Schmidt, R .
STROKE, 2001, 32 (02) :405-412